Literature DB >> 17855552

Relaxed repression of herpes simplex virus type 1 genomes in Murine trigeminal neurons.

Tracy Terry-Allison1, Colton A Smith, Neal A DeLuca.   

Abstract

The expression of herpes simplex virus (HSV) genomes in the absence of viral regulatory proteins in sensory neurons is poorly understood. Previously, our group reported an HSV immediate early (IE) mutant (d109) unable to express any of the five IE genes and encoding a model human cytomegalovirus immediate early promoter-green fluorescent protein (GFP) transgene. In cultured cells, GFP expressed from this mutant was observed in only a subset of infected cells. The subset exhibited cell type dependence, as the fractions of GFP-expressing cells varied widely among the cell types examined. Herein, we characterize this mutant in murine embryonic trigeminal ganglion (TG) cultures. We found that d109 was nontoxic to neural cultures and persisted in the cultures throughout their life spans. Unlike with some of the cultured cell lines and strains, expression of the GFP transgene was observed in a surprisingly large subset of neurons. However, very few nonneuronal cells expressed GFP. The abilities of ICP0 and an inhibitor of histone deacetylase, trichostatin A (TSA), to activate GFP expression from nonexpressing cells were also compared. The provision of ICP0 by infection with d105 reactivated quiescent genomes in nearly every cell, whereas reactivation by TSA was much more limited and restricted to the previously nonexpressing neurons. Moreover, we found that d109, which does not express ICP0, consistently reactivated HSV type 1 (KOS) in latently infected adult TG cultures. These results suggest that the state of persisting HSV genomes in some TG neurons may be more dynamic and more easily activated than has been observed with nonneuronal cells.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17855552      PMCID: PMC2168976          DOI: 10.1128/JVI.01068-07

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  95 in total

1.  Herpes simplex virus latent RNA (LAT) is not required for latent infection in the mouse.

Authors:  D Y Ho; E S Mocarski
Journal:  Proc Natl Acad Sci U S A       Date:  1989-10       Impact factor: 11.205

2.  A herpes simplex virus type 1 mutant containing a deletion within immediate early gene 1 is latency-competent in mice.

Authors:  G B Clements; N D Stow
Journal:  J Gen Virol       Date:  1989-09       Impact factor: 3.891

3.  Immediate-early regulatory gene mutants define different stages in the establishment and reactivation of herpes simplex virus latency.

Authors:  D A Leib; D M Coen; C L Bogard; K A Hicks; D R Yager; D M Knipe; K L Tyler; P A Schaffer
Journal:  J Virol       Date:  1989-02       Impact factor: 5.103

4.  During latency, herpes simplex virus type 1 DNA is associated with nucleosomes in a chromatin structure.

Authors:  S L Deshmane; N W Fraser
Journal:  J Virol       Date:  1989-02       Impact factor: 5.103

5.  Potent and specific inhibition of mammalian histone deacetylase both in vivo and in vitro by trichostatin A.

Authors:  M Yoshida; M Kijima; M Akita; T Beppu
Journal:  J Biol Chem       Date:  1990-10-05       Impact factor: 5.157

6.  Herpes simplex virus type 1 ICP27 deletion mutants exhibit altered patterns of transcription and are DNA deficient.

Authors:  A M McCarthy; L McMahan; P A Schaffer
Journal:  J Virol       Date:  1989-01       Impact factor: 5.103

7.  A herpes simplex virus type 1 latency-associated transcript mutant reactivates with normal kinetics from latent infection.

Authors:  T M Block; J G Spivack; I Steiner; S Deshmane; M T McIntosh; R P Lirette; N W Fraser
Journal:  J Virol       Date:  1990-07       Impact factor: 5.103

8.  Herpes simplex virus type 1 ICP0 plays a critical role in the de novo synthesis of infectious virus following transfection of viral DNA.

Authors:  W Z Cai; P A Schaffer
Journal:  J Virol       Date:  1989-11       Impact factor: 5.103

9.  Herpes simplex virus type 1 latency-associated transcription plays no role in establishment or maintenance of a latent infection in murine sensory neurons.

Authors:  F Sedarati; K M Izumi; E K Wagner; J G Stevens
Journal:  J Virol       Date:  1989-10       Impact factor: 5.103

10.  Herpes simplex virus transactivator ICP4 operationally substitutes for the cellular transcription factor Sp1 for efficient expression of the viral thymidine kinase gene.

Authors:  A N Imbalzano; D M Coen; N A DeLuca
Journal:  J Virol       Date:  1991-02       Impact factor: 5.103

View more
  28 in total

1.  Reversal of heterochromatic silencing of quiescent herpes simplex virus type 1 by ICP0.

Authors:  Michael W Ferenczy; Neal A DeLuca
Journal:  J Virol       Date:  2010-12-29       Impact factor: 5.103

2.  A viral E3 ligase targets RNF8 and RNF168 to control histone ubiquitination and DNA damage responses.

Authors:  Caroline E Lilley; Mira S Chaurushiya; Chris Boutell; Sebastien Landry; Junghae Suh; Stephanie Panier; Roger D Everett; Grant S Stewart; Daniel Durocher; Matthew D Weitzman
Journal:  EMBO J       Date:  2010-01-14       Impact factor: 11.598

3.  Herpes simplex viral-vector design for efficient transduction of nonneuronal cells without cytotoxicity.

Authors:  Yoshitaka Miyagawa; Pietro Marino; Gianluca Verlengia; Hiroaki Uchida; William F Goins; Shinichiro Yokota; David A Geller; Osamu Yoshida; Joseph Mester; Justus B Cohen; Joseph C Glorioso
Journal:  Proc Natl Acad Sci U S A       Date:  2015-03-16       Impact factor: 11.205

4.  Cellular Antisilencing Elements Support Transgene Expression from Herpes Simplex Virus Vectors in the Absence of Immediate Early Gene Expression.

Authors:  Fang Han; Yoshitaka Miyagawa; Gianluca Verlengia; Selene Ingusci; Marie Soukupova; Michele Simonato; Joseph C Glorioso; Justus B Cohen
Journal:  J Virol       Date:  2018-08-16       Impact factor: 5.103

5.  Regulation of ICP0-null mutant herpes simplex virus type 1 infection by ND10 components ATRX and hDaxx.

Authors:  Vera Lukashchuk; Roger D Everett
Journal:  J Virol       Date:  2010-02-10       Impact factor: 5.103

6.  In vivo disruption of latent HSV by designer endonuclease therapy.

Authors:  Martine Aubert; Emily A Madden; Michelle Loprieno; Harshana S DeSilva Feelixge; Laurence Stensland; Meei-Li Huang; Alexander L Greninger; Pavitra Roychoudhury; Nixon Niyonzima; Thuy Nguyen; Amalia Magaret; Roman Galleto; Daniel Stone; Keith R Jerome
Journal:  JCI Insight       Date:  2016-09-08

7.  ICP0 dismantles microtubule networks in herpes simplex virus-infected cells.

Authors:  Mingyu Liu; Edward E Schmidt; William P Halford
Journal:  PLoS One       Date:  2010-06-08       Impact factor: 3.240

8.  Promyelocytic leukemia-nuclear body proteins: herpesvirus enemies, accomplices, or both?

Authors:  Ryan T Saffert; Robert F Kalejta
Journal:  Future Virol       Date:  2008-05-01       Impact factor: 1.831

9.  Epigenetic modulation of gene expression from quiescent herpes simplex virus genomes.

Authors:  Michael W Ferenczy; Neal A DeLuca
Journal:  J Virol       Date:  2009-06-17       Impact factor: 5.103

10.  ICP0 antagonizes ICP4-dependent silencing of the herpes simplex virus ICP0 gene.

Authors:  Mingyu Liu; Brandon Rakowski; Edward Gershburg; Carla M Weisend; Olivier Lucas; Edward E Schmidt; William P Halford
Journal:  PLoS One       Date:  2010-01-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.